269 filings
8-K
TXMD
TherapeuticsMD Inc
10 May 24
TherapeuticsMD Announces First Quarter 2024 Financial Results
4:15pm
8-K
TXMD
TherapeuticsMD Inc
29 Mar 24
TherapeuticsMD Announces Full Year 2023 Financial Results
4:29pm
8-K
TXMD
TherapeuticsMD Inc
14 Nov 23
TherapeuticsMD Announces Third Quarter 2023 Financial Results
4:25pm
8-K
TXMD
TherapeuticsMD Inc
18 Aug 23
Entry into a Material Definitive Agreement
5:18pm
8-K
TXMD
TherapeuticsMD Inc
14 Aug 23
TherapeuticsMD Announces Second Quarter 2023 Financial Results
7:15am
8-K
n222uhf0je740
10 Jul 23
Changes in Registrant's Certifying Accountant
5:20pm
8-K
9zq5sg xc
6 Jul 23
Unregistered Sales of Equity Securities
4:38pm
8-K
cuz1x 4q9yh
28 Jun 23
Submission of Matters to a Vote of Security Holders
7:00am
8-K
ztgi1rv
15 May 23
TherapeuticsMD Announces First Quarter 2023 Financial Results
4:16pm
8-K
dtqmq6kymh6x59
5 May 23
Entry into a Material Definitive Agreement
5:26pm
8-K
yl4ilat6va4mgd43 p25
21 Apr 23
Other Events
5:14pm
8-K
6u3zzl3bx vche
7 Apr 23
TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition
4:41pm
8-K
gqmfpg dj2mu539ne
27 Feb 23
Departure of Directors or Certain Officers
4:27pm
8-K
ci55u71bhbwjh9bl1n
18 Jan 23
Departure of Directors or Certain Officers
5:00pm
8-K
3ti1ssmznz
12 Jan 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:01pm
8-K/A
mjfwyyz37 3w1yxtq
6 Jan 23
Departure of Directors or Certain Officers
5:30pm
8-K
tg2mwfcv avv
3 Jan 23
TherapeuticsMD Completes Transaction to License its Products to Mayne Pharma
7:00am
8-K
xqz5sh 5x9
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
8-K
ogn09fw
1 Dec 22
Entry into a Material Definitive Agreement
9:23am
8-K
b66jw1l7 di
14 Nov 22
TherapeuticsMD Announces Third Quarter 2022 Financial Results
4:24pm